Tag: Vascular access
Xeltis receives IDE approval from US FDA for haemodialysis vascular access...
Xeltis has announced that it has gained approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) submission to...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation of five-year data from the IN.PACT AV Access study evaluating the IN.PACT AV (Medtronic) drug-coated balloon (DCB) today led principal investigator...
BD launches vascular access ultrasound system
BD, a leading global medical technology company, have launched a new advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted...
New UKKA guideline places patient choice at heart of vascular access...
The recent haemodialysis access guideline update from the UK Kidney Association (UKKA), which was published in the run-up to the 2023 UK Kidney Week...
Teleflex announces US FDA clearance of Arrow EZ-IO Needle for use...
Teleflex has announced in a press release that the Arrow EZ-IO Needle is the first and only intraosseous (IO) needle to receive 510(k) clearance from...
Interventional News’ top 10 most popular stories of May 2023
Interventional News’ most popular stories from May included a forecast of where embolization is headed from a Global Embolization Oncology Symposium (GEST, 18–21 May,...
Xeltis presents six-month first-in-human data on aXess graft
Xeltis has presented “highly-encouraging” six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society (VAS;...
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
Nipro to bring Cronus high-pressure PTA balloon catheter to USA
Nipro Medical Corporation is set to introduce its second-generation Cronus high-pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter to the US market.
Cronus HP is...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
Sweeping technological advances enable interventional radiologists to close in on crucial...
Nicholas Inston (consultant vascular access and renal transplant surgeon, Birmingham, UK) discusses the crucial care interventional radiologists provide for renal patients with Ian Mcafferty...
Ellipsys™ Vascular Access System provides consistently great outcomes for AV fistula...
Alexandros Mallios (Paris, France) and Robert Shahverdyan (Hamburg, Germany) talk to Vascular News about some of the benefits of the Ellipsys™ Vascular Access System...
Amplifi vein dilation system demonstrates “encouraging” clinical results in haemodialysis access
Artio Medical has announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium...
Results from first-in-human study of Amplifi vein dilation system presented at...
Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at Vascular Interventional Advances (VIVA) 2021 (5–7 October...
Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...
Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...
New standardised reporting system suggests arteriovenous graft infections may be less...
“Using an objective system that discriminates between aetiology and outcome allows a more complete, objective understanding of relative infection risks and outcomes for arteriovenous...
LINC 2021 first time data releases in arteriovenous access: Positive results...
New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) are positive for the IN.PACT AV drug-coated...
Artio Medical announces successful first human use of the Amplifi vein...
Artio Medical recently announced that it has successfully completed the first human use of its Amplifi vein dilation system. The first clinical procedure was...
Largest US nephrology group is first in Illinois to offer Ellipsys...
Nephrology Associates of Northern Illinois and Indiana (NANI), the largest nephrology group in the USA, is the first practice in Illinois to adopt the Ellipsys vascular access system (Avenu Medical, now...
Network meta-analysis finds DCB angioplasty “significantly superior” to plain balloon angioplasty...
A recent network meta-analysis shows that, in failing arteriovenous fistulas (AVFs) with outflow stenosis, drug-coated balloon (DCB) angioplasty is “significantly superior” to plain balloon...
COVID-related hypercoagulability linked to elevated malfunction rate in temporary haemodialysis catheters
Hypercoagulability in COVID-19 patients leads to an increase in the malfunction rate of temporary haemodialysis catheters—but heparin locking of the catheters is linked to...
Risk of ischaemic steal syndrome and patency rate comparable for tapered...
In their recent systematic review and meta-analysis, Venkata Sai Jasty (University of Arizona, Tuscon, USA) and colleagues found that the risk of ischaemic steal...
New protocol helps identify best venipuncture site for femoral access
RaFeVA (Rapid Femoral Vein Assessment), a new protocol, is a rapid and effective tool for the systematic ultrasound evaluation of the veins in the...
Older age and diabetes mellitus identified as risk factors for poor...
Different risk factors affect patency between vascular access construction and the first percutaneous transluminal angioplasty, Mahoko Yoshida (Hiroshima University Hospital, Hiroshima, Japan) and colleagues...
Clinician survey reveals significant variation in ultrasound-guided PIV insertion
A new survey among vascular access (VA) and emergency department (ED) clinicians has revealed significant levels of variation in ultrasound-guided peripheral IV (UGPIV) practices...
Teleflex announces expanded indications for the Arrow EZ-IO intraosseous vascular access...
Teleflex has announced it has received 510(k) clearance from the US Food and Drug Administration to expand the indications for use of the Arrow...
Dialysis access needs to be a priority in the COVID-19 era
Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...
Patient-specific computation model may improve AVF maturation rates
The results of a randomised controlled trial—the Shunt simulation study—show that a new patient-specific computation model accurately calculated postoperative access flow. As flow is...
New study shows advantages of Ellipsys system in creating reliable dialysis...
A new study shows significant benefits of the Ellipsys vascular access system (Avenu Medical) in easily and safely creating durable vascular access for end-stage...
CX 2020 LIVE: Vascular Access session showcases new technologies, while debate...
The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking...
Published real-world experience demonstrates VasQ External Support improves outcomes when adopted...
Robert Shahverdyan, head of the Vascular Access Center at Asklepios Klinik Barmbek, Hamburg, Germany, has recently published a retrospective analysis of his first 32...
IVUS during haemodialysis access “aids device selection and adequacy of treatment”
Narayan Karunanithy outlines the benefits of intravascular ultrasound (IVUS) during haemodialysis access intervention.
Thoracic central veins include intra-thoracic segments of the internal jugular, subclavian, brachiocephalic...
A thumbnail sketch of haemodialysis access: Past, present, and future in...
Bart Dolmatch gives an overview of the history of haemodialysis access in the USA, and balances the pros and cons of current access options....
Adept Medical launches the Antegrade IR platform
Adept Medical has launches its Antegrade IR platform, which provides a work surface for antegrade femoral approach during interventional radiology vascular procedures. The device...
No significant differences between hybrid and open approaches for managing thrombosed...
Data from the University of Pittsburgh Medical Center (Pittsburgh, USA) indicate that the open approach to managing thrombosed haemodialysis grafts with venous anastomotic lesions...
“More creative solutions” needed for end-stage vascular access patients
Nicholas (Nick) Inston calls for “more creative solutions” to vascular access challenges, commending interventional radiologists’ innovative reputation as instrumental to increasing the number of...
Merit Medical launches new PreludeSYNC EVO radial compression device
Merit Medical have announced the commercial launch of the PreludeSYNC EVO radial compression device in the USA. The PreludeSYNC EVO is a sterile, single-use,...
SAVE-US pivotal trial completes enrollment and has positive clinical results
The SAVE-US (Surfacer system to facilitate access in venous occlusions—United States) pivotal trial has completed enrollment. The SAVE-US trial is evaluating the safety and...
Comparing and contrasting surgically-created AVFs with those made by endovascular means
Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...
AngioDynamics provides update on vascular access business
AngioDynamics has provided a corporate update and acknowledged a recent, favourable US District Court ruling that impacts its vascular access business.
A press release states...
EchoNous Vein receives FDA approval
EchoNous Vein (EchoNous), an ultrasound-based tool designed specifically for nurses to improve peripheral IV catheter placements, has received US Food and Drug Administration (FDA)...
BD acquires TVA Medical, makers of everlinQ endoAVF System
BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...
FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation
Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...
Humacyte appoints Jeffrey Lawson as president and CEO
Humacyte, an innovator in biotechnology and regenerative medicine, has announced that Jeffrey Lawson has been appointed president and chief executive officer. The former chairman...
